Table 3 Care management via NETSARC/GSF-GETO network
Local sarcoma with NO further metastatic lines | Local sarcoma WITH further metastatic lines | Sarcoma initially metastatic | Total | ||
|---|---|---|---|---|---|
N = 213 | N = 76 | N = 69 | N = 358 | ||
Initial care by the NetSarc network | N | 213 | 76 | 69 | 358 |
No | n (%) | 196 (92.0%) | 67 (88.2%) | 62 (89.9%) | 325 (90.8%) |
Yes | n (%) | 17 (8.0%) | 9 (11.8%) | 7 (10.1%) | 33 (9.2%) |
Full treatment course | N | 213 | 76 | 69 | 358 |
Outside the GSF-GETO network | n (%) | 136 (63.8%) | 44 (57.9%) | 33 (47.8%) | 213 (59.5%) |
Care by the GSF-GETO network only | n (%) | 7 (3.3%) | 5 (6.6%) | 4 (5.8%) | 16 (4.5%) |
Mixed care | n (%) | 70 (32.9%) | 27 (35.5%) | 32 (46.4%) | 129 (36.0%) |